.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Healthcare procurement transparency is a vital pillar for the financial sustainability of Indian hospitals. Recently, Affordplan and the Association of Healthcare Providers (India) – Tamil Nadu Chapter (AHPI-TN) signed a strategic Memorandum of Understanding. This collaboration introduces the Procalyx platform to healthcare facilities across the state. Consequently, member hospitals can now access advanced tools for price discovery and procurement optimization. This initiative aims to modernize the supply chain through data-driven decisions.
The healthcare sector in India has long struggled with fragmented supply chain data. This issue often leads to significant price variations for identical drugs and medical consumables. Therefore, implementing a standardized framework is essential for modern hospitals. The Procalyx platform provides real-time market benchmarks to eliminate these disparities. By utilizing such technology, administrators can make more informed purchasing decisions. This move directly enhances healthcare procurement transparency and improves overall operational efficiency for medical institutions.
Digital tools like Procalyx allow hospitals to verify market rates for pharmaceuticals and devices instantly. Moreover, this system reduces the manual overhead associated with traditional procurement processes. Hospitals can also improve their financial visibility without compromising the quality of patient care. AHPI-TN members will receive preferential access and dedicated support for system integration. Furthermore, this partnership marks a significant step toward a resilient healthcare ecosystem in Tamil Nadu. Such advancements ensure that hospitals remain sustainable while providing high-quality services.
Q1: What is the primary objective of the Affordplan and AHPI-TN partnership?
The primary objective is to replace information asymmetry with data-driven decision-making in hospital procurement using the Procalyx platform.
Q2: How does Procalyx benefit hospital administrators?
It enables administrators to benchmark prices for pharmaceuticals and medical devices in real time, leading to smarter purchasing cycles and cost efficiencies.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Affordplan and AHPI-TN partner to launch Procalyx, an AI-driven platform enhancing healthcare procurement transparency and cost efficiency in Tamil Nadu....
5 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
